Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Deal Origination Executive Search For Sales Teams Corporate Development For Founders For Agencies For Investors Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Start Free
Mito BioPharm logo — Pioneering advanced therapeutics through precision modulatio...

Mito BioPharm

Pioneering advanced therapeutics through precision modulation of mitochondrial function for transformative healthcare solutions in metabolic diseases.

Founded 2012 Biotechnology, Health Care +1

General Information

Company Name Mito BioPharm
Founded Year 2012
Founders / Decision Makers
Team member
Industries Biotechnology, Health Care, Pharmaceutical
Social

Get notified when Mito BioPharm moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Mito BioPharm

Mito BioPharm is a biotechnology startup founded in 2012 with a focus on pioneering advanced therapeutics through precision modulation of mitochondrial function. The company specializes in developing therapeutics by targeting mitochondria and modulating cellular metabolism. Mitochondria play a crucial role in cellular metabolism, with alterations in their function being significantly linked to diseases such as NASH, type 2 diabetes, lipid disorders, neurodegenerative diseases, cancer, and general aging. Mito BioPharm employs a proprietary, small molecule-based technology exclusively licensed from Rutgers University to adjust mitochondrial functions. This technology is anticipated to significantly influence the development of new drugs in the therapeutic fields of liver-based diseases including NASH, type 2 diabetes, and specific liver-based orphan diseases. The company has already identified IND leads for NASH and type 2 diabetes, with IND-enabling studies expected to commence in 2019. The R&D team is also working on an expanded pipeline of candidate compounds for other metabolic-related conditions to fully leverage its platform technology. The company's mission to develop transformative healthcare solutions in metabolic diseases aligns with the industry sectors of Biotechnology, Health Care, and Pharmaceuticals. While specific details about the company's headquarters and latest investments are not available, Mito BioPharm's innovative approach towards targeting mitochondrial function and addressing metabolic diseases positions it as an intriguing player in the biotechnology and pharmaceutical sectors, offering potential opportunities for venture capital investment.

Taxonomy: Biopharmaceutical, Mitochondria, Cellular metabolism, Therapeutics, NASH, Type 2 diabetes, Lipid disorders, Neurodegenerative diseases, Cancer, Aging, Small molecule-based technology, Rutgers University, Liver-based diseases, Orphan diseases, IND-enabling studies

No funding data available for Mito BioPharm yet.

Get notified when Mito BioPharm raises funding

Mito BioPharm Alternatives & Competitors

Mito BioPharm vs
Minovia Therapeutics
Minovia Therapeutics Israel

A clinical-stage international biotechnology research company focused on treatment innovation for mi...

28 employees
Mito BioPharm vs
RiboNova, Inc.
RiboNova, Inc. United States

Focused on Mitochondrial Disease & other serious rare diseases. R007 is our P2 ready asset, we also...

Series Unknown
7 employees
Biotechnology, Pharmaceutical
Mito BioPharm vs
Satellite Bio
Satellite Bio United States

Tackling some of humankind’s most elusive diseases with Tissue Therapeutics, a new category of regen...

Series A
24 employees
Biotechnology, Pharmaceutical

FAQ About Mito BioPharm

Pioneering advanced therapeutics through precision modulation of mitochondrial function for transformative healthcare solutions in metabolic diseases.
Mito BioPharm was founded in 2012.
Mito BioPharm operates in the following industries: Biotechnology, Health Care, Pharmaceutical.
Top alternatives and competitors to Mito BioPharm include Minovia Therapeutics , RiboNova, Inc., Satellite Bio, Breathe Again, Longeveron Inc. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Mito BioPharm and Minovia Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Mito BioPharm and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

Start Tracking — Free

One analytics cookie (Google Analytics). Cookie Policy